RASSF1 and neoplasm: They found RASSF1A promoter hypermethylation was remarkably related to tumor size (p = 0.028) but not significantly associated with sex (p = 0.094), age (p = 0.152), HCV infection (p = 0.928), level of AFP (p = 0.657), and tumor number (p = 0.410).